MA28740B1 - Methodes de traitement d'infections endobronchiques - Google Patents

Methodes de traitement d'infections endobronchiques

Info

Publication number
MA28740B1
MA28740B1 MA29618A MA29618A MA28740B1 MA 28740 B1 MA28740 B1 MA 28740B1 MA 29618 A MA29618 A MA 29618A MA 29618 A MA29618 A MA 29618A MA 28740 B1 MA28740 B1 MA 28740B1
Authority
MA
Morocco
Prior art keywords
treating
methods
endobronic
infections
patient
Prior art date
Application number
MA29618A
Other languages
English (en)
Inventor
Peter Challoner
Carlos Rodriguez
Thomas E Tarara
John D Lord
Original Assignee
Novartis Vaccines & Diagnostic
Nektar Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic, Nektar Therapeutics filed Critical Novartis Vaccines & Diagnostic
Publication of MA28740B1 publication Critical patent/MA28740B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des méthodes de traitement d'une infection endobronchique chez un patient par administration, dans le système endobronchique du patient, d'une composition sous forme d'aérosol de poudre sèche comprenant entre 90 et 130 mg d'un antibiotique aminoglycoside, une à trois fois par jour pendant une première période de traitement de 20 à 36 jours.
MA29618A 2004-06-18 2007-01-17 Methodes de traitement d'infections endobronchiques MA28740B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58084804P 2004-06-18 2004-06-18

Publications (1)

Publication Number Publication Date
MA28740B1 true MA28740B1 (fr) 2007-07-02

Family

ID=35782127

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29618A MA28740B1 (fr) 2004-06-18 2007-01-17 Methodes de traitement d'infections endobronchiques

Country Status (25)

Country Link
US (3) US20080214481A1 (fr)
EP (1) EP1765288B1 (fr)
JP (3) JP2008503500A (fr)
KR (2) KR20120131245A (fr)
CN (1) CN101014320B (fr)
AU (1) AU2005258078B2 (fr)
BR (1) BRPI0512146A (fr)
CA (1) CA2570976C (fr)
DK (1) DK1765288T3 (fr)
EC (1) ECSP077182A (fr)
ES (1) ES2399279T3 (fr)
HR (1) HRP20130076T1 (fr)
IL (1) IL179873A (fr)
MA (1) MA28740B1 (fr)
MX (1) MXPA06014567A (fr)
NO (1) NO338799B1 (fr)
NZ (1) NZ552047A (fr)
PL (1) PL1765288T3 (fr)
PT (1) PT1765288E (fr)
RU (1) RU2389477C2 (fr)
SG (1) SG153833A1 (fr)
SI (1) SI1765288T1 (fr)
TN (1) TNSN06420A1 (fr)
WO (1) WO2006002178A1 (fr)
ZA (1) ZA200700420B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514393A (ja) * 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
CA2665764C (fr) * 2006-10-11 2015-05-26 Laboratoires Smb S.A. Composition pharmaceutique anti-infectieuse pour inhalation
EP1938822A1 (fr) * 2006-12-21 2008-07-02 Novartis AG Thérapie combinée pour le traitement des maladies des voies respiratoires
JP5727927B2 (ja) 2008-05-15 2015-06-03 ノバルティス アーゲー フルオロキノロンの肺送達
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
SI3106149T1 (sl) * 2009-05-29 2020-07-31 Pearl Therapeutics, Inc. Sestavki za pljučno dostavo muskarinskih antagonistov z dolgotrajnim delovanjem in agonistov beta-2 adrenergičnega receptorja z dolgotrajnim delovanjem in povezani postopki in sistemi
EP2473963A4 (fr) 2009-08-31 2014-01-08 Abbott Diabetes Care Inc Dispositifs et procédés médicaux
AU2010333173B2 (en) * 2009-12-14 2016-08-25 Chiesi Farmaceutici S.P.A. Antibiotic microparticles for inhalation
EP4248866A3 (fr) 2010-03-24 2023-12-20 Abbott Diabetes Care, Inc. Dispositifs d'insertion de dispositifs médicaux et procédés d'insertion et d'utilisation de dispositifs médicaux
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
CA2841272C (fr) 2011-07-12 2019-01-15 Alan Bruce Montgomery Formulations de combinaisons d'amikacine et de fosfomycine et procedes et systemes pour le traitement de la pneumonie associee au ventilateur (pav) et de la tracheobronchite assoc iee au ventilateur (tav)
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
DK3831283T3 (da) 2011-12-11 2023-05-30 Abbott Diabetes Care Inc Analytsensorindretninger, forbindelser og fremgangsmåder
WO2014055456A1 (fr) * 2012-10-07 2014-04-10 Abbott Diabetes Care Inc. Indicateurs d'introduction de dispositif médical
CN102949379B (zh) * 2012-11-14 2014-11-05 中山大学 硫酸奈替米星吸入粉雾剂及其制备方法
HK1219059A1 (zh) 2013-03-15 2017-03-24 珍珠治疗公司 用於微粒晶体材料的状态调节的方法和系统
CA2984939A1 (fr) 2015-05-14 2016-11-17 Abbott Diabetes Care Inc. Instruments d'introduction de dispositifs medicaux compacts et systemes et procedes associes
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
WO2018136898A1 (fr) 2017-01-23 2018-07-26 Abbott Diabetes Care Inc. Systèmes, dispositifs et procédés pour l'insertion de capteur d'analyte
US12521041B2 (en) 2018-12-21 2026-01-13 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte sensor insertion
WO2020163416A1 (fr) * 2019-02-05 2020-08-13 Mylan Inc Dispositifs et procédés de traitement par inhalation de tobramycine
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
US12239463B2 (en) 2020-08-31 2025-03-04 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte sensor insertion
US12569168B2 (en) 2020-09-15 2026-03-10 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte monitoring
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
FR2224175B1 (fr) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
GB8314308D0 (en) 1983-05-24 1983-06-29 Matburn Holdings Ltd Medical administration devices
SU1335297A1 (ru) * 1984-06-15 1987-09-07 Донецкий медицинский институт им.М.Горького Способ лечени больных хроническими заболевани ми легких
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8909891D0 (en) 1989-04-28 1989-06-14 Riker Laboratories Inc Device
IT1243344B (it) 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
DE69230613T2 (de) 1991-07-02 2000-12-28 Inhale Inc Verfahren und vorrichtung zum abgeben von medikamenten in aerosolform
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
WO1995031479A1 (fr) 1994-05-18 1995-11-23 Inhale Therapeutic Systems, Inc. Procedes et compositions pour produire des interferons sous forme de poudre seche
JP3706136B2 (ja) 1994-09-21 2005-10-12 ネクター セラピューティクス 乾燥粉末薬剤の分散装置及び方法
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
KR19980703876A (ko) 1995-04-14 1998-12-05 스티븐 엘. 허스트 분산성이 개선된 분말화된 약학적 조성물
US5826633A (en) 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
HU226729B1 (en) * 1998-05-27 2009-08-28 Euro Celtique Sa Preparation for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract
AU778797B2 (en) * 1998-12-17 2004-12-23 Novartis Vaccines And Diagnostics, Inc. Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
CA2382821A1 (fr) 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation de liberation a partir de formulations seches en poudre
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2001085136A2 (fr) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Poudres a base de phospholipides permettant de distribuer un medicament
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US20030143162A1 (en) 2001-05-18 2003-07-31 Speirs Robert John Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
DE10131917A1 (de) 2001-07-02 2003-01-23 Infineon Technologies Ag Verfahren zur Erzeugung einer stufenförmigen Struktur auf einem Substrat
JP4437040B2 (ja) 2001-11-14 2010-03-24 ネクター セラピューティクス 接続可能な本体およびエンドピースを備えるエーロゾル化装置
WO2003041777A1 (fr) 2001-11-14 2003-05-22 Nektar Therapeutics Dispositif a aerosol comprenant un embout de raccordement ameliore
JP2005514393A (ja) * 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
JP4739672B2 (ja) 2001-12-21 2011-08-03 ネクター セラピューティクス 湿気のバリアを有するカプセルパッケージ
JP2005530765A (ja) 2002-05-07 2005-10-13 ネクター セラピューティクス 乾燥粉末吸入器のためのカプセル及びそれを製造及び使用する方法
CN1493297A (zh) * 2003-09-13 2004-05-05 南昌弘益科技有限公司 妥布霉素吸入粉雾剂及其制备方法

Also Published As

Publication number Publication date
US8664187B2 (en) 2014-03-04
CN101014320A (zh) 2007-08-08
US20120148641A1 (en) 2012-06-14
PT1765288E (pt) 2013-01-29
DK1765288T3 (da) 2013-02-11
CA2570976C (fr) 2013-08-13
PL1765288T3 (pl) 2013-04-30
HRP20130076T1 (hr) 2013-03-31
EP1765288B1 (fr) 2012-11-07
NO20070253L (no) 2007-03-13
RU2007101906A (ru) 2008-07-27
AU2005258078A1 (en) 2006-01-05
AU2005258078B2 (en) 2010-09-30
US20080214481A1 (en) 2008-09-04
CN101014320B (zh) 2011-05-18
BRPI0512146A (pt) 2008-02-12
ECSP077182A (es) 2007-05-30
EP1765288A4 (fr) 2009-05-13
KR20120131245A (ko) 2012-12-04
IL179873A0 (en) 2007-05-15
US20110097412A1 (en) 2011-04-28
MXPA06014567A (es) 2007-07-24
NO338799B1 (no) 2016-10-24
SI1765288T1 (sl) 2013-02-28
JP2008503500A (ja) 2008-02-07
TNSN06420A1 (en) 2008-02-22
JP2012107047A (ja) 2012-06-07
IL179873A (en) 2014-09-30
KR20070026604A (ko) 2007-03-08
ZA200700420B (en) 2008-05-28
RU2389477C2 (ru) 2010-05-20
ES2399279T3 (es) 2013-03-27
EP1765288A1 (fr) 2007-03-28
NZ552047A (en) 2009-11-27
SG153833A1 (en) 2009-07-29
WO2006002178A1 (fr) 2006-01-05
CA2570976A1 (fr) 2006-01-05
JP2013056947A (ja) 2013-03-28

Similar Documents

Publication Publication Date Title
MA28740B1 (fr) Methodes de traitement d'infections endobronchiques
WO2001092288A3 (fr) Composes de cobalamine utilises comme agents antibiotiques et comme agents d'imagerie
TNSN08194A1 (fr) Compositions pharmaceutiques solides contenant de la pregabaline
SG170119A1 (en) Nutritional composition comprising indigestible oligosaccharides
BRPI0414000B8 (pt) composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica
NO20076219L (no) Farmasoytisk formulering med apomorfin for bukkal administrering
FR2700117B1 (fr) Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
MY145647A (en) (4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states)
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
MA27059A1 (fr) Azithromycine en dose unique
WO2006072940A3 (fr) Preparation pharmaceutique a liberation prolongee et controlee destinee a etre utilisee dans la cavite buccale
GB2446341A (en) Method and system for transdermal drug delivery
MA26788A1 (fr) COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION
BR0011845A (pt) Complexo farmacêutico
WO2005056520A8 (fr) Composes actifs du sous-type 1 de recepteur de somatostatine (sstr1) et leur utilisation en therapie
MD2211F1 (en) Remedy for treatment of parodontium affections
HUP0301408A2 (hu) Szulodexid alkalmazása diabetikus vesebetegség kezelésére szolgáló orális gyógyszerkészítmény előállítására
TNSN00211A1 (fr) Derives d'hygromycine a nouveaux, compositions les contenant et leur utilisation
BR0112035A (pt) peptìdeos antimicrobianos de novispirin
EA200400691A1 (ru) Получение чистых стереоизомеров трицикло[5,2,1,02,6]дец-9-ил-ксантогената и содержащие их лекарственные средства
MA29813B1 (fr) Combinaisons pharmaceutiques contenant de la lamivudine, de la stavudine et de la nevirapine
HUP0202888A2 (hu) Xenogén oligo- és/vagy poliribonukleotidokat tartalmazó gyógyszerkészítmény
CY1113562T1 (el) Σκευασματα τομπραμυκινης για τη θεραπεια ενδοβρογχικων λοιμωξεων
AU2001250722A1 (en) Medicament for the treatment of diseases caused by parasitic protozoa